Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118010 · ClinicalTrials.gov registry record · Phase 4
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT04118010 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 40 participants.
The verdict
NCT04118010, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The study will assess if administration of high-dose vitamin D and a commonly used prebiotic (inulin) is effective to reduce gastrointestinal dysbiosis and to improve critical intestinal functions in Cystic Fibrosis with the additive or synergistic effects of the combination of vitamin D + inulin.
Interventions
- DRUG Inulin
- DRUG Vitamin D3
- DRUG Placebo vitamin D3
- DRUG Placebo Inulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-03-13 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04118010
The ClinicalTrials.gov registry entry for NCT04118010 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Inulin is the first listed.
NCT04118010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04118010 about?
NCT04118010 is a clinical study titled "Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis". The study will assess if administration of high-dose vitamin D and a commonly used prebiotic (inulin) is effective to reduce gastrointestinal dysbiosis and to improve critical intestinal functions in Cystic Fibrosis with the additive or synergistic effects of the combination of vitamin D + inulin.
What is the current status of trial NCT04118010?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2020-03-13. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04118010?
The interventions under investigation include: Inulin (DRUG), Vitamin D3 (DRUG), Placebo vitamin D3 (DRUG), Placebo Inulin (DRUG).
Who is sponsoring clinical trial NCT04118010?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.